Neoadjuvant immunotherapy given for stage III melanoma, followed by adjuvant therapy only if there is not...

Osimertinib improves PFS in patients with unresectable stage III EGFR-mutated non-small cell lung cancer (NSCLC)...

The antibody-drug conjugate trastuzumab deruxtecan delays cancer growth for women with hormone receptor-positive (HR+)...

According to a new study presented at the 2024 ASCO Annual Meeting, adding the antibody-drug conjugate...

For patients with locally advanced oesophageal adenocarcinoma that can be treated with surgery, chemotherapy treatment...

Results from a new study presented at the 2024 American Society of Clinical Oncology (ASCO) Annual...

Artificial intelligence (AI) is here to stay and is well on its way to transforming how...

The Irish Society of Rheumatology (ISR) 2024 Spring Meeting was “a great success with a wide...

Interferon seems to raise migraine risk in people with MS, while rituximab may lower it. A...

The American Headache Society recently issued a position statement update on the use of migraine prevention...

Prof Geoffrey Rose, Consultant Orbital, Lacrimal and Plastic Reconstructive Surgeon...

Therapeutic cancer vaccines are being heralded as the next big thing in the rapidly advancing field...